Novo Nordisk A/S
 
Search
 Search

Changing diabetes®


Changing the future of diabetes
We are dedicated to changing diabetes - how it is treated, how it is viewed around the world, and how the future of this disease plays out.

As a world leader in diabetes care, we believe this is our responsibility…and it's a goal that cannot be achieved through science alone. We have to effect change at every level - in science and research, in humanitarianism and outreach efforts, in education, and in government and public policy worldwide.

We at Novo Nordisk are committed to defeating this disease in our lifetime, and the resources we dedicate to diabetes research are unparalleled in the industry. We can win, but only if we all work together.

Changing how we treat diabetes
Novo Nordisk was one of the first companies to introduce insulin to the world, and since then we have helped to change how diabetes is treated.

Changing how we look at diabetes
Research and development alone are not enough. To reach our goal of defeating diabetes as quickly as possible, we need the cooperation and support of public policymakers around the world.

Launched by Novo Nordisk in 2001, the World Diabetes Foundation (WDF) supports the prevention and treatment of diabetes where it is most needed. Providing education, healthcare infrastructure, drug procurement and distribution, and ongoing monitoring and mentoring of patients, this independent non-profit organization has so far supported 164 projects in 77 countries and impacted 56 million people worldwide.

We continue to work with policymakers and healthcare systems to effectively address the growing threat of diabetes in the general population through our National Changing Diabetes Program in the United States.

Changing how we work with diabetes
Novo Nordisk is committed to pursuing its business goals as a profitable enterprise in a way that is also socially and environmentally responsible. Our Triple Bottom Line approach to doing business ensures that we remain balanced: it’s not just about making a profit, but also about how profits are earned.

This kind of effort has to start from within. TakeAction! is an employee volunteer program that includes volunteering in developing countries, fundraising, environmental outreach, and the sharing of best practices among affiliates.

Changing how we live with diabetes
Nothing is more important to us than helping to improve the lives of people living with diabetes. Our job is to inspire hope and deliver real solutions that fit the way people want to live.

DAWN (Diabetes Attitudes, Wishes, and Needs) is a global program led by Novo Nordisk to improve psychosocial support for people with diabetes. DAWN aims to empower healthcare providers and patients to put the emphasis back on the person with the disease, instead of a rigidly clinical approach to treatment.

Changing diabetes®
We can enable people with diabetes to live their lives on their own terms…

We can embrace the advancements that our future research will bring…

We can stay financially competitive without losing our ideals…

And we can help people in everything we do.

Novo Nordisk is leading the fight against diabetes. Defeating diabetes is our passion and our business. Facing this growing epidemic together, we know we can reach our goal of changing diabetes - and defeating it.